NPPA seeks clarification on license status from Clotrimazole mouth paint manufacturers - Video
|
Overview
In relation to the fixation of ceiling price of antifungal drug clotrimazole 1% mouth paint, the National Pharmaceutical Pricing Authority (NPPA) panel has sought to get a clarification of approval of license status from the manufacturers and marketer of the drug.
This came during the 38th meeting of 'Multidisciplinary Committee of Experts' meeting which was held on 24.01.2022 through video conference.
For more information, check out the full story on the link below:
NPPA seeks clarifications regarding ceiling price fixation of Clotrimazole mouth paint
